-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2019 to Q1 2024.
- BioXcel Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.61M, a 7.13% increase year-over-year.
- BioXcel Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $13.6M, a 17.1% increase year-over-year.
- BioXcel Therapeutics, Inc. annual Interest Expense for 2023 was $13.3M, a 62.1% increase from 2022.
- BioXcel Therapeutics, Inc. annual Interest Expense for 2022 was $8.21M, a 20433% increase from 2021.
- BioXcel Therapeutics, Inc. annual Interest Expense for 2021 was $40K, a 48.1% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)